MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.
about
Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma'Micro-managers' of hepatic lipid metabolism and NAFLDMiR-155 Enhances Insulin Sensitivity by Coordinated Regulation of Multiple Genes in MiceMicroRNAs in fibrosis: opportunities and challengesAn Interferon Regulated MicroRNA Provides Broad Cell-Intrinsic Antiviral Immunity through Multihit Host-Directed Targeting of the Sterol PathwayEpigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field.MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatmentThe role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosisNeurorestorative therapy for strokeMicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritismicroRNAs and HDL life cycle.Micro RNAs in the development of non-alcoholic fatty liver disease.Overexpression of miR-155 in the liver of transgenic mice alters the expression profiling of hepatic genes associated with lipid metabolism.AAV8-mediated in vivo overexpression of miR-155 enhances the protective capacity of genetically attenuated malarial parasitesMicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis.Nutritional systems biology of type 2 diabetesHigh-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH.MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders.Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different gradesMechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis.The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis.microRNA regulation of lipoprotein metabolism.Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease.Relevance of microRNA in metabolic diseases.MicroRNA regulation of mitochondrial and ER stress signaling pathways: implications for lipoprotein metabolism in metabolic syndrome.T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.Scavenger receptors and non-coding RNAs: relevance in atherogenesis.MicroRNAs in dysfunctional adipose tissue: cardiovascular implications.Role of MicroRNAs in NAFLD/NASH.miRNAs and High-Density Lipoprotein metabolism.Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling.Ratio of microRNA-122/155 in isoniazid-induced acute liver injury in mice.High protein/fish oil diet prevents hepatic steatosis in NONcNZO10 mice; association with diet/genetics-regulated micro-RNAsmiR155 deficiency aggravates high-fat diet-induced adipose tissue fibrosis in male mice.Posttranscriptional regulation of lipid metabolism by non-coding RNAs and RNA binding proteins.Driving chronicity in rheumatoid arthritis - perpetuating role of myeloid cells.
P2860
Q26767346-9B6C43A2-8F7A-48F8-ACEF-C54890DF0867Q26801228-03E48E75-83FB-4DF0-B1BD-6975B7CD61EEQ27307894-3908C039-0FD9-4536-A8F9-0BF23FFC49B8Q28067380-4A224999-A03C-49A3-9163-5564CEA4E205Q28550521-711AA8D8-D0A2-4238-9846-8B92B79FD0B3Q30400120-2542363D-BADA-4C6F-BEA5-875C4CBE79C8Q33607587-9A26A00F-EC8D-4F45-83A4-FAD61C8F9403Q33758285-D665C992-D66C-46F9-B9FB-0151FBB4BC42Q33813333-2B18CC5F-B46D-41D9-B344-0DC8798E1F09Q33849824-A50A66A3-DDCA-4FF1-8362-8369ABBF804EQ34248289-643172E3-8B0E-4E40-8F7D-C1FABFC6B5B8Q35127045-E62DCC67-1DE7-4CDD-B2C1-663FC62941EFQ35208224-44839123-909D-4B93-9BAB-F68F4B33C410Q35600319-A7DFD375-E139-4BFC-BBAE-C847BF3462B1Q35652509-1FD3CBC1-CD30-493E-A6AD-E1B147472662Q35883431-FA459E18-85E6-4C16-BFAB-DE362DDAD251Q35958233-D04C8AC1-CAEB-4E2D-8DFA-4EBB20C28696Q36329460-D3BB03FE-3B98-4665-8E7C-4E48E4A2E735Q36428863-BEF0792B-E69B-42E7-856B-7756CC332562Q36459815-80625151-D276-4459-9AE2-0FCB24DD121DQ36504308-1F076792-C599-4961-AAB6-A1B5C2B7A2E3Q36599274-A93E4BE1-E656-4722-96E4-AD68A4F90662Q36764809-3A9DA117-8A7C-43FA-8C55-8694B53EA525Q36912465-A7CD746F-86E4-4569-9638-434A200E1DD0Q36922236-2D8F8238-6BBA-46BF-8C14-60D3C0818437Q37650119-6CD72041-8275-426B-BC27-5C9F1BFE29B7Q38202220-F288F124-89B3-42A8-B235-69E3C09ED756Q38230799-D76E0D71-690D-496E-96AB-00AF8092B445Q38245790-C76BD717-4E3B-4023-9DFE-71CBEEECFDC2Q38430526-400680F9-5BEF-483F-B546-8FAE43E2B88EQ38608471-C67C4D1F-CDFE-4F2C-ACBE-AED975FE7286Q38683783-0583C25F-84A3-4B77-89C8-BA4CE2D757FAQ38697221-926A1C8F-AC95-47CD-9F89-D2BA3280C14FQ38730644-A9BBA0E1-3706-47B2-93FC-79F16DC5A493Q38876354-F348802C-DA60-4F54-AAB8-7D9E1EF5E3F0Q41867355-DF3B253A-3C46-44D8-9086-33CE55CAF7D0Q41940630-CC58D349-6098-400C-954F-FA73F3E31155Q42365565-14DE5021-E11B-4414-A580-4A99D290A2CCQ46252515-C8376CCF-BE11-4AF1-A643-5DAF002DB768Q47189951-C91CE29F-51E4-4A3C-A73B-8964704AEF6F
P2860
MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
MiR-155 has a protective role ...... holic hepatosteatosis in mice.
@ast
MiR-155 has a protective role ...... holic hepatosteatosis in mice.
@en
type
label
MiR-155 has a protective role ...... holic hepatosteatosis in mice.
@ast
MiR-155 has a protective role ...... holic hepatosteatosis in mice.
@en
prefLabel
MiR-155 has a protective role ...... holic hepatosteatosis in mice.
@ast
MiR-155 has a protective role ...... holic hepatosteatosis in mice.
@en
P2093
P2860
P1433
P1476
MiR-155 has a protective role ...... holic hepatosteatosis in mice.
@en
P2093
Ashley M Miller
Carlos Fernández-Hernando
Christopher A Lavery
Cristina M Ramirez
Derek S Gilchrist
Jagtar Nijjar
Mariola Kurowska-Stolarska
P2860
P304
P356
10.1371/JOURNAL.PONE.0072324
P407
P577
2013-08-21T00:00:00Z